Hyperuricaemia elevates circulating CCL2 levels and primes monocyte trafficking in subjects with inter-critical gout

Rheumatology (United Kingdom)

Volumn 52, Issue 6, 2013, Pages 1018-1021

  Grainger, Rebecca ^a   McLaughlin, Rene J ^a   Harrison, Andrew A ^b   Harper, Jacquie L ^a  

^a UNIVERSITY OF OTAGO   (New Zealand)

^b UNIVERSITY OF OTAGO   (New Zealand)

Author keywords

CCL2; Gout; Hyperuricaemia; Inflammation; Monocytes

Indexed keywords

CD11B ANTIGEN; CD14 ANTIGEN; MONOCYTE CHEMOTACTIC PROTEIN 1; URIC ACID;

ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE ASSOCIATION; FLOW CYTOMETRY; GOUT; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERURICEMIA; MONOCYTE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; UPREGULATION; URIC ACID BLOOD LEVEL;

CCL2; GOUT; HYPERURICAEMIA; INFLAMMATION; MONOCYTES;

AGED; ANTIGENS, CD14; CELL MOVEMENT; CHEMOKINE CCL2; FEMALE; GOUT; HUMANS; HYPERURICEMIA; MALE; MIDDLE AGED; MONOCYTES; URIC ACID;

EID: 84878133549     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes326     Document Type: Article

References (19)

1. Martin WJ, Walton M, Harper J. Resident macrophages initiating and driving inflammation in a monosodium urate monohydrate crystal-induced murine peritoneal model of acute gout. Arthritis Rheum 2009;60:281-9.
2. Schiltz C, Liote F, Prudhommeaux F et al. Monosodium urate monohydrate crystal-induced inflammation in vivo: quantitative histomorphometric analysis of cellular events. Arthritis Rheum 2002;46:1643-50.
3. Rollins BJ. Monocyte chemoattractant protein 1: a potential regulator of monocyte recruitment in inflammatory disease. Mol Med Today 1996;2:198-204.
4. Serbina NV, Pamer EG. Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2. Nat Immunol 2006;7:311-7.
5. Matsukawa A, Miyazaki S, Maeda T et al. Production and regulation of monocyte chemoattractant protein-1 in lipopolysaccharide-or monosodium urate crystal-induced arthritis in rabbits: roles of tumor necrosis factor alpha, interleukin-1, and interleukin-8. Lab Invest 1998;78: 973-85.
6. Kanellis J, Watanabe S, Li JH et al. Uric acid stimulates monocyte chemoattractant protein-1 production in vascular smooth muscle cells via mitogen-activated protein kinase and cyclooxygenase-2. Hypertension 2003;41: 1287-93.
7. Wasilewska A, Tenderenda E, Taranta-Janusz K, Tobolczyk J, Stypulkowska J. Markers of systemic inflammation in children with hyperuricemia. Acta Paediatr 2012;101:497-500.
8. Ruggiero C, Cherubini A, Ble A et al. Uric acid and inflammatory markers. Eur Heart J 2006;27:1174-81.
9. Martin WJ, Grainger R, Harrison A, Harper JL. Differences in MSU-induced superoxide responses by neutrophils from gout subjects compared to healthy controls and a role for environmental inflammatory cytokines and hyperuricemia in neutrophil function and survival. J Rheumatol 2010;37:1228-35.
10. Jiang Y, Beller DI, Frendl G, Graves DT. Monocyte chemoattractant protein-1 regulates adhesion molecule expression and cytokine production in human monocytes. J Immunol 1992;148:2423-8.
11. Kang DH, Han L, Ouyang X et al. Uric acid causes vascular smooth muscle cell proliferation by entering cells via a functional urate transporter. Am J Nephrol 2005;25: 425-33.
12. Krishnan E, Baker JF, Furst DE, Schumacher HR. Gout and the risk of acute myocardial infarction. Arthritis Rheum 2006;54:2688-96.
13. Choi HK, Curhan G. Independent impact of gout on mortality and risk for coronary heart disease. Circulation 2007; 116:894-900.
14. Cukurova S, Pamuk ON, Unlu E, Pamuk GE, Cakir N. Subclinical atherosclerosis in gouty arthritis patients: a comparative study. Rheumatol Int 2012;32:1769-73.
15. Kocaman SA, Sahinarslan A, Cemri M, Timurkaynak T, Boyaci B, Cengel A. Independent relationship of serum uric acid levels with leukocytes and coronary atherosclerotic burden. Nutr Metab Cardiovasc Dis 2009;19: 729-35.
16. Coll B, Alonso-Villaverde C, Joven J. Monocyte chemoattractant protein-1 and atherosclerosis: is there room for an additional biomarker? Clin Chim Acta 2007;383: 21-9.
17. Nasir K, Guallar E, Navas-Acien A, Criqui MH, Lima JA. Relationship of monocyte count and peripheral arterial disease: results from the National Health and Nutrition Examination Survey 1999-2002. Arterioscler Thromb Vasc Biol 2005;25:1966-71.
18. Gerszten RE, Tager AM. The monocyte in atherosclerosis- should I stay or should I go now? N Engl J Med 2012;366:1734-6.
19. Woollard KJ, Geissmann F. Monocytes in atherosclerosis: subsets and functions. Nat Rev Cardiol 2010;7: 77-86.